Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Burkitt Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lung Neoplasms 6Breast Neoplasms 6Meningeal Carcinomatosis 5Leukemia, Myeloid, Acute 5Carcinoma, Non-Small-Cell Lung 5Lymphoma, Large B-Cell, Diffuse 4Leukemia, Biphenotypic, Acute 4Myelodysplastic Syndromes 3Glioblastoma 3Astrocytoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Glioma 2Brain Neoplasms 2Uveal Melanoma 1Rhabdomyosarcoma 1Oligodendroglioma 1Nevus 1Neoplastic Cells, Circulating 1Neoplasm Recurrence, Local 1Multiple Myeloma 1Meningioma 1Meningeal Neoplasms 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1

Interventions

Rituximab 7Vemurafenib 4Cyclophosphamide 4Cladribine 4Specimen Handling 3Biopsy 3obinutuzumab 2ibrutinib 2fludarabine phosphate 2fludarabine 2binimetinib 2Diphenhydramine 2Dexamethasone 2Calcium Dobesilate 2CT-P10 2Acetaminophen 2venetoclax 1tovorafenib 1polatuzumab vedotin 1pembrolizumab 1immunotoxin HA22 1encorafenib 1dexamethasone acetate 1dexamethasone 21-phosphate 1brexucabtagene autoleucel 1auricularum 1acalabrutinib 1Whole-Body Irradiation 1Valganciclovir 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Hairy Cell × Spinal Puncture × 1 year × Clear all
NCT06311227 2026-05-13

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

National Cancer Institute (NCI)

Phase 2 Recruiting
20 enrolled
Other hematologic neoplasm

Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡